SCLERODEX
Google image searchProduct monograph
Active ingredients
dextrose, 250 MG/ML
sodium chloride, 100 MG/ML
DIN: 02020939
Dosage form(s): LIQUID
Route(s) of administration: INTRAVENOUS
Schedule: Ethical
Company: OMEGA LABORATORIES LIMITED
Date: 31-DEC-1977
ATC:
- C05 — VASOPROTECTIVES (ATC, ATC/DDD, )
- C05B — ANTIVARICOSE THERAPY (ATC, ATC/DDD)
- C05BB — Sclerosing agents for local injection (ATC, ATC/DDD)
- C05BB56 — GLUCOSE, COMBINATIONS (ATC/DDD)
